Filing Details

Accession Number:
0001572795-21-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-09 17:46:51
Reporting Period:
2021-01-13
Accepted Time:
2021-02-09 17:46:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510964 Cv Sciences Inc. CVSI Pharmaceutical Preparations (2834) 800944970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1572795 Jr Joseph Michael Mona 10070 Barnes Canyon Road
San Diego CA 92121
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-13 100,000 $0.61 1,928,660 No 4 S Direct
Common Stock Disposition 2021-01-14 100,000 $0.63 1,828,660 No 4 S Direct
Common Stock Disposition 2021-01-15 16,600 $0.66 1,812,060 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.619 to $0.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. As of the date of this filing, the reporting person owns a total of 1,986,722 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 1,812,060 shares of common stock of the issuer.